Medistim — Interim / Quarterly Report 2016

Oct 19, 2016

3rd quarter financial report 2016 for Medistim ASA

3rd quarter financial report 2016 for Medistim ASA

Sales ended at MNOK 67.9 for the quarter (MNOK 61.6),

a 10.2 % growth. Sales as of September increased by

13.5 % and ended at MOK 200.6 (MNOK 176.8). The

revenue growth is driven by sales of own products and

currency neutral growth was 13.0 % for the quarter and

16.1 % YTD. Operating profit (EBIT) for the quarter

ended at MNOK 15.9 (MNOK 12.7). Operating profit as of

September ended at MNOK 46.6 (MNOK 34.3.) an increase

of 36.0 %.

The 3rd quarter was a new record quarter in the US

with a currency neutral growth of 14.9 %. Also a

strong sales of ultrasound imaging products in Asia

and Australia contributed to the growth in the 3rd

quarter.

Profit per share increased with 8.6 % for the quarter

and ended at NOK 0.62 (NOK 0.57). Accumulated profit

per share was NOK 1.83 (NOK 1.56).